Background Among physicians who treat patients with acute myocardial infarction, there is
controversy about the magnitude of the clinical benefit of primary (ie, immediate) coronary …

BACKGROUND: Among physicians who treat patients with acute myocardial infarction, there
is controversy about the magnitude of the clinical benefit of primary (ie, immediate) coronary …

OBJECTIVES This study sought to compare the two-year outcome after primary
percutaneous coronary angioplasty or thrombolytic therapy for acute myocardial infarction …

Objectives. We sought to determine the relative cost and effectiveness of two different
reperfusion modalities in patients with acute myocardial infarction (AMI). Background …

Background The success of thrombolytic therapy for acute myocardial infarction is limited by
bleeding complications, the impossibility of reperfusing all occluded coronary arteries …

The mortality benefit of thrombolytic therapy for acute myocardial infarction (AMI) is strongly
dependent on time to treatment. Recent observations suggest that time to treatment may be …

OBJECTIVES We sought to determine the effectiveness of primary angioplasty compared
with thrombolysis in clinical practice. BACKGROUND In clinical practice, primary angioplasty …

We compared the efficacy of immediate coronary angioplasty after acute myocardial
infarction with that of elective angioplasty at 7 to 10 days in patients treated initially with …

Background Immediate angioplasty and the administration of a thrombolytic agent followed
by conservative treatment are two approaches to the management of acute myocardial …

Background As compared with thrombolytic therapy, primary coronary angioplasty results in
a higher rate of patency of the infarct-related coronary artery, lower rates of stroke and …